Clinical value of 99mTc-MIBI scintigraphy combined with posttherapeutic 131I whole-body scanning in patients with differentiated thyroid cancer with sTg ≥10 ng/mL before initial radioiodine therapy: a retrospective study
Quantitative Imaging in Medicine and Surgery · 2025-10 · 15 (10) · 9534-9544
DOI: 10.21037/qims-2025-571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Quantitative Imaging in Medicine and Surgery, 2025-10. Verfasst von Na Han und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The 2015 American Thyroid Association (ATA) guidelines indicate that patients with stimulated thyroglobulin (sTg) ≥10 ng/mL may need further evaluations. It has been reported that Technetium-99m-methoxyisobutylisonitrile (99mTc-MIBI) scintigraphy offers a reliable and easy means of detecting metastases in patients with differentiated thyroid cancer (DTC). The principal aim of this study was to investigate the clinical value of 99mTc-MIBI scintigraphy combined with posttherapeutic 131I-whole-body scanning (pt-131I WBS) in patients with DTC and sTg ≥10 ng/mL before initial radioactive iodine therapy (RAIT). Additionally, we analyzed the differences in the therapeutic efficacy of RAIT among different groups.
Methods
In this study, 195 patients with DTC with sTg ≥10 ng/mL before initial RAIT were enrolled. The images of 99mTc-MIBI scintigraphy and pt-131I WBS were then divided into four groups as follows: group 1, 99mTc-MIBI scintigraphy positive and pt-131I WBS positive; group 2, 99mTc-MIBI scintigraphy negative and pt-131I WBS positive; group 3, 99mTc-MIBI scintigraphy positive and pt-131I WBS negative; and group 4, 99mTc-MIBI scintigraphy negative and pt-131I WBS negative. The response to RAIT was classified as excellent response (ER), indeterminate response (IDR), biochemical incomplete response (BIR), and structural incomplete response (SIR) according to the 2015 ATA guidelines. The efficacy of RAIT in different groups was further analyzed.
Results
The diagnostic sensitivity (χ2=55.442; P 0.05). The difference in response to RAIT between group 4 and group 2 (P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nuclear Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.
Zitieren
APA
Han, N., Li, J., Lu, C., Si, Z., Zhang, Y., Wang, G., Liu, X., Wang, C., Li, F., & Wang, X. (2025). Clinical value of 99mTc-MIBI scintigraphy combined with posttherapeutic 131I whole-body scanning in patients with differentiated thyroid cancer with sTg ≥10 ng/mL before initial radioiodine therapy: a retrospective study. Quantitative Imaging in Medicine and Surgery, 15(10), 9534-9544. https://doi.org/10.21037/qims-2025-571
Vancouver
Han N, Li J, Lu C, Si Z, Zhang Y, Wang G, et al. Clinical value of 99mTc-MIBI scintigraphy combined with posttherapeutic 131I whole-body scanning in patients with differentiated thyroid cancer with sTg ≥10 ng/mL before initial radioiodine therapy: a retrospective study. Quantitative Imaging in Medicine and Surgery. 2025;15(10):9534-9544. doi:10.21037/qims-2025-571
BibTeX
@article{Han2025,
author = {Han, Na and Li, Jiao and Lu, Chenghui and Si, Zengmei and Zhang, Yingying and Wang, Guoqiang and Liu, Xinfeng and Wang, Congcong and Li, Fengqi and Wang, Xufu},
title = {Clinical value of 99mTc-MIBI scintigraphy combined with posttherapeutic 131I whole-body scanning in patients with differentiated thyroid cancer with sTg ≥10 ng/mL before initial radioiodine therapy: a retrospective study},
journal = {Quantitative Imaging in Medicine and Surgery},
year = {2025},
volume = {15},
number = {10},
pages = {9534--9544},
doi = {10.21037/qims-2025-571}
}
EUVIMED